Sample collection for serious drug skin reactions
Part of Immune system & allergy, Mouth & dental, Skin clinical trials.
This study collects skin and blood samples from adults who have a serious rash caused by medicines. The goal is to better understand these reactions and how to diagnose them sooner and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You have had a serious skin reaction that was likely caused by a medicine
- Examples include severe rashes like AGEP, DRESS, SJS/TEN, or similar reactions
- You must be able to sign the study consent form
- You need to have social security affiliation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests stem-cell treatment to help people with severe skin reactions called SJS-TEN. It may reduce ongoing skin damage and help recovery when treatment is started soon after symptoms begin.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This trial tests a targeted therapy for people with a severe drug reaction called DRESS syndrome. It may help control the overactive immune response and reduce organ damage.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study collects skin samples and medical information from people with skin conditions caused by their immune system. It helps researchers better understand these diseases and develop new treatments.
Hear when a new Stevens-Johnson Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.